Pautas E - Search Results

1

Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.

Siguret V, Gouin-Thibault I, Gaussem P, Pautas E. Siguret V, et al. Among authors: pautas e. Drugs Aging. 2013 Sep;30(9):687-99. doi: 10.1007/s40266-013-0101-0. Drugs Aging. 2013. PMID: 23884865 Review.

2

[Macrophage activation in a 74-year-old man].

Niel F, Pautas E, Beauchef A, Andreux MH, Gaussem P, Andreux JP, Siguret V. Niel F, et al. Among authors: pautas e. Ann Biol Clin (Paris). 1998 Nov-Dec;56(6):729-33. Ann Biol Clin (Paris). 1998. PMID: 9853035 Free article. French. No abstract available.

3

[Myelodysplastic syndromes. Diagnosis and care in patients over 70 years of age].

Pautas E, Gaillard M, Chambon-Pautas C, Siguret V, Andreux JP, Gaussem P. Pautas E, et al. Presse Med. 1999 Oct 23;28(32):1771-8. Presse Med. 1999. PMID: 10566284 Review. French.

4

[Myelodysplastic syndromes].

Garandeau C, Pautas E, Andreux M, Andreux J, Gaussem P, Siguret V. Garandeau C, et al. Among authors: pautas e. Ann Biol Clin (Paris). 2000 Jul-Aug;58(4):405-16. Ann Biol Clin (Paris). 2000. PMID: 10932040 Free article. Review. French.

5

Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days.

Siguret V, Pautas E, Février M, Wipff C, Durand-Gasselin B, Laurent M, Andreux JP, d'Urso M, Gaussem P. Siguret V, et al. Among authors: pautas e. Thromb Haemost. 2000 Nov;84(5):800-4. Thromb Haemost. 2000. PMID: 11127859

6

[Monitoring of tinzaparin in a ten day treatment dose in elderly patients].

Pautas E, Siguret V, d'Urso M, Laurent M, Gaussem P, Février M, Durand-Gasselin B. Pautas E, et al. Rev Med Interne. 2001 Feb;22(2):120-6. doi: 10.1016/s0248-8663(00)00301-5. Rev Med Interne. 2001. PMID: 11234669 Clinical Trial. French.

7

Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.

Pautas E, Gouin I, Bellot O, Andreux JP, Siguret V. Pautas E, et al. Drug Saf. 2002;25(10):725-33. doi: 10.2165/00002018-200225100-00005. Drug Saf. 2002. PMID: 12167068 Clinical Trial.

8

[Oral anticoagulants in the elderly].

Debray M, Pautas E, Couturier P, Franco A, Siguret V. Debray M, et al. Among authors: pautas e. Rev Med Interne. 2003 Feb;24(2):107-17. doi: 10.1016/s0248-8663(02)00020-6. Rev Med Interne. 2003. PMID: 12650892 Review. French.

9

[Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey].

Siguret V, Esquirol C, Debray M, Gouin I, Andreux JP, Pautas E. Siguret V, et al. Among authors: pautas e. Presse Med. 2003 Jun 14;32(21):972-7. Presse Med. 2003. PMID: 12876525 French.

10

Heparin-releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days.

Gouin-Thibault I, Pautas E, Depasse F, Andreux JP, Siguret V. Gouin-Thibault I, et al. Among authors: pautas e. J Thromb Haemost. 2003 Dec;1(12):2694-5. doi: 10.1111/j.1538-7836.2003.0543k.x. J Thromb Haemost. 2003. PMID: 14675115 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters